Representatives from the North East and North
Cumbria Integrated Care Board (ICB) will be in attendance to provide:
·
details
of the services available to meet the reproductive health and general health
needs of women throughout their life course; and
·
an update on the development of
women’s health hubs and how the local hub model will be tailored to meet local
population needs.
Minutes:
The Director of Place Based Delivery and the
Commissioning Delivery Manager from the North East and
North Cumbria Integrated Care Board (ICB) were in attendance to provide
information on the women’s health programme.
The Commissioning Delivery Manager advised that
the Department of Health and Social Care (DHSC) had recently published the
Women’s Health Strategy for England, which set out 10-year ambitions for
boosting the health and wellbeing of women and girls, and for improving how the
health and care system listened to women. The strategy encouraged the expansion
of women’s health hubs across the country to improve access to services and
health outcomes. The DHSC had recently
announced a £25 million investment, nationally, to create new women’s health
hubs, as part of the Women’s Health Strategy for England. It was explained that
North East and North Cumbria ICB had been allocated
£595,000.
The scrutiny panel heard that:
·
51%
of the population were women;
·
59%
of women were unpaid carers;
·
78%
of the NHS workforce were women; and
·
82%
of the social care workforce were women.
In terms of national health challenges, the
following areas were outlined:
·
Although
women lived longer than men, women’s heathy life expectancy was less than men.
·
Contraception
was difficult to access.
·
45%
of pregnancies were unplanned or ambivalent.
·
Abortion
rates were rising in women over 22 years old, often because they were unable to
access long-acting reversible contraception (LARC), such as the implant or the
coil.
·
Maternal
mortality was 4x higher in black women and 2x higher in Asian women.
·
Suicide
was the leading cause of direct maternal death in the first postnatal year (UK
and IE).
·
35%
of women who were eligible for screening had not been tested in over three
years, which could have saved approximately 1400 lives in England per year.
·
Women
from more deprived areas were less likely to take up breast screening.
·
Menopause
symptoms lasted for an average duration of 7 years and around a quarter of
women suffered severe symptoms.
·
Since
2018:
o
in
the most affluent areas of England, there had been a 4-fold increase in the
number of women accessing Hormone Replacement Therapy (HRT); and
o
in
the most deprived areas of England, there had been a 2.5-fold increase in the
number of women accessing HRT.
·
1
in 3 women over 60 years old experienced urinary incontinence.
·
The
symptoms for cardiovascular disease varied for women, and women often received
their diagnosis later than men.
·
Osteoporosis
and frailty were major causes of morbidity and mortality for women.
The priority areas of the Government’s Women’s
Health Strategy included:
·
Menstrual
health and gynaecological conditions;
·
Fertility,
pregnancy, pregnancy loss and post-natal support;
·
Menopause;
·
Mental
health and wellbeing;
·
Cancers;
·
The
health impacts of violence against women and girls; and
·
Healthy
aging and long-term conditions.
In terms of the regional context, for the area
of the North East and North Cumbria, the following
information was outlined:
·
The
gap in life expectancy between the most and least deprived
neighbourhoods had increased for both males and females.
·
Women
lived longer than men, but on average women lived longer in poor health.
·
Women
in the region were not looking after themselves e.g.
breast screening uptake.
·
There
were wide inequalities in health e.g., HRT.
·
Around
28% of working-age women were economically inactive, compared to 22% of men.
·
Nearly
a third of girls and women lived in the 20% most deprived neighbourhoods across
England.
·
Levels
of access to LARCs had not yet returned to pre-pandemic levels and were lower
than England levels.
·
Abortion
rates, including under 25s repeat abortions, were on an upward trend.
·
The
rate of emergency hospital admissions for intentional self-harm was
significantly higher in girls and women.
·
Over
a quarter of women (27%) had a diagnosis of anxiety.
·
In
2021, the leading causes of death for all ages of women were cancer, followed
by circulatory disease, dementia, and Alzheimer’s,
·
Musculoskeletal
conditions, fractures and hospital admissions due to
falls, were much more likely to affect women than men.
·
The
rate of falls, for women, was significantly higher than the England average.
In terms of regional work, the following areas
were outlined to the scrutiny panel:
·
A
regional Women's Health Steering Group, Operational Group and Community of
Practice had been established, with Tees Valley representation.
·
A
North East and North Cumbria Women’s Health Strategy
Conference had been held in October 2023, with the Office for Health
Improvement and Disparities (OHID).
·
Work
had been undertaken to map the progress of ongoing initiatives, regionally, and
liaise with place leads for women’s health.
·
Work
had been undertaken to understand population need in the Tees Valley and
develop insights by analysing population health management data (across the
region, the Tees Valley had been the first area to complete that work).
·
Work
had been undertaken to map existing commissioned services across the Tees
Valley, against the aims of the Women's Health Strategy. Following
completion of the work, gaps in provision, risks, issues
and key areas of focus were identified for the Tees Valley.
·
Work
had been undertaken with the voluntary community sector to identify other
service provision that was available locally.
Members were informed that each ICB place,
including the Tees Valley, had been invited to bid for the available funding of
£595,000, from Government, to develop at least one Women's Health
Hub within the North East and North Cumbria
footprint. The Tees Valley had submitted a proposal, outlining the key areas of
focus, including the menopause and LARC. Unfortunately, the Tees Valley’s bid
had been unsuccessful and the funding had been awarded
to Sunderland, Gateshead and North Cumbria. Those areas had been awarded the
funding to test the concept of the women’s health hubs. It was then hoped that,
depending on the outcomes, funding would become available to other areas to
improve local services.
As part of wider Tees Valley stakeholder
engagement, the following key areas had been identified:
·
improve
Menopause/HRT offer;
·
improve
access to contraception - Long Acting Reversible
Contraception (LARC) and Emergency Hormonal Contraception (EHC);
·
pessary
fitting/removal for prolapse; and
·
increase
uptake of cervical screening.
It was commented that to strengthen/develop
existing service provision there was a need to improve access and deliver
clinics for those individuals who were born females, but who no longer
identified as women. There was also a need to improve access for women with
learning disabilities.
The ICB had engaged with HealthWatch
to seek feedback on experiences of women’s health services, particularly
support for the menopause.
The ICB was currently developing the North East and North Cumbria Women’s Health Programme to
take forward the implementation of the national strategy. The next steps were
outlined to the scrutiny panel:
·
Following
completion of the current service provision mapping exercise, information and
data would be consolidated and analysed to identify opportunities and gaps,
which align to local needs and the strategic aims of the Women’s Health
Strategy.
·
The
Women's Health Collaborative would use collective knowledge to spread and
share information and focus on initial priorities and opportunities.
·
A
communication, engagement and involvement strategy would be aligned to the development
and implementation of the programme.
·
Feedback
from HealthWatch would be utilised to inform service
improvement/development.
A Member raised a query regarding breast cancer
diagnosis during pregnancy. In response, the Director of Place Based Delivery
advised that the Tees Valley benefitted from symptomatic breast service one
stop outpatient provision at the University Hospital of North Tees. Following
diagnosis, the majority of patients received
treatment/surgery at their local hospital sites. The ICB was focused on
promoting collaborative working and the delivery of clear pathways, which aimed
to ensure, for instance, that those on a maternal pathway were referred to the
diagnostic one stop provision if they found a lump in their breast - to ensure
a quick diagnosis. Work was being undertaken to ensure that a consistent offer
was available. It was added that, unfortunately, there was not sufficient
healthcare capacity to offer a similar service at James Cook University
Hospital.
A Member raised a query regarding accessibility
to services. In response, the Commissioning Delivery Manager advised feedback
received had indicated that barriers had been encountered in terms of the
accessibility of services. It was commented that the implementation of the hub
model would have undoubtedly improved accessibility but unfortunately the Tees
Valley had not been successful in securing funding to do that. The Director of
Place Based Delivery advised that the Tees Valley was fortunate, as the area
had many different health facilities and the service provision available met
the needs of the local population of women. However, work was needed to improve
accessibility to those services. Available opening hours was one specific area
that required further consideration. The ICB was also mindful that there was a
need to overcome perceived stigma by re-branding services. A Member commented
on the importance of women’s health services being welcoming.
A Member raised a query regarding women’s
health hubs. In response, the Director of Place Based
Delivery advised that women’s health hubs were a concept, which aimed to
bring women’s health services together in a more accessible way. It was a
network of services that could be accessed by visiting one location. The
funding available was for a one-off investment that was ringfenced specifically
to co-locate services. The Tees Valley was already fortunate to have an
extensive amount of women’s health services that were already grouped together.
However, the importance of those services communicating with one another was
highlighted, as was the need to ensure that there were not multiple points of
contact for women when they were trying to access services. It was highlighted
that Sunderland, Gateshead and North Cumbria would be delivering those women’s
health services from one particular location.
A Member raised a query regarding the outcomes
of the town-wide initiative to promote breastfeeding in public places. The
Director of Public Health advised that data, in respect of initiation and
maintenance rates, would be circulated to the scrutiny panel. The Mayor and
Executive Member for Adult Social Care and Public Health commented that in
terms of breastfeeding, in Middlesbrough, rates differed drastically between
the more affluent areas and the most deprived areas.
A Member raised a query regarding maternal
mortality being 4x higher in black women. The Commissioning Delivery Manager
advised that the data had been reported nationally. It was commented that
information would be shared with the scrutiny panel on disparities in outcomes
for women, depending on their ethnicity. The Director of Place Based Delivery
commented that work was being undertaken by the ICB to track access and equity
of provision with an aim to pinpoint cultural barriers and improve access.
A Member raised a query regarding the partners
that the ICB had engaged with to map current service provision. In response,
the Commissioning Delivery Manager advised that a document, detailing the
feedback received from partners, would be shared with the scrutiny panel.
A Member raised a query about incidences of
domestic abuse. In response, the Director of Place Based Delivery advised that
specific safeguarding procedures were in place. It was added that data,
regarding disclosures to health professionals, would be circulated to the
scrutiny panel.
A discussion ensued regarding the Women’s
Health Strategy. The importance of analysing data and information, to
demonstrate/evidence improved outcomes for women, was highlighted.
AGREED
That
the information presented to the scrutiny panel be noted.
Supporting documents: